OmniAb (OABI) Treasury Shares (2022 - 2026)
OmniAb (OABI) reported Treasury Shares of $2.2 million for Q1 2026, up 1.72% year-over-year from $2.1 million in Q1 2025, and up 34.18% quarter-over-quarter from $1.6 million in Q4 2025.
OmniAb (OABI) Treasury Shares (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Treasury Shares data on file, last reported at $2.2 million in Q1 2026.
- Treasury Shares for Q1 2026 came in at $2.2 million, up 1.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 1.72% YoY), and the FY2025 annual result was $1.6 million, down 7.48% from the prior year.
- Treasury Shares climbed to $2.2 million in Q1 2026 per OABI's latest filing, from $1.6 million in the prior quarter.
- Over five years, Treasury Shares peaked at $2.3 million in Q1 2024 and troughed at $94749.0 in Q4 2022.
- A 5-year average of $1.4 million and a median of $1.9 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares soared 2353.23% in 2024, then declined 7.54% in 2025.
- A 5-year view of Treasury Shares shows it stood at $94749.0 in 2022, then jumped by 1882.48% to $1.9 million in 2023, then fell by 6.24% to $1.8 million in 2024, then declined by 7.48% to $1.6 million in 2025, then jumped by 34.18% to $2.2 million in 2026.
- Business Quant data shows OABI's Treasury Shares at $2.2 million in Q1 2026, $1.6 million in Q4 2025, and $2.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.19 Mn |
| Mar 31, 2026 | 2.19 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | 94,749.00 |
| Sep 30, 2024 | 94,749.00 |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 1.88 Mn |
| Dec 31, 2023 | 1.88 Mn |
| Sep 30, 2023 | 94,749.00 |
| Sep 30, 2023 | 94,749.00 |